Date:12/12/2012

d changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.Investor Relations Contacts Misonix Contact:

Lytham Partners, LLCRichard Zaremba

Robert Blum, Joe Dorame, Joe Diaz631-694-9555

602-889-9700invest@misonix.com 

mson@lythampartners.com

'/>"/>

SOURCE Misonix, Inc. Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
2. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
3. Misonix Product Featured At Neurosurgery Congress
4. Misonix Adds 6 Spine Sales Agencies In The U.S.
5. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
6. Misonix Inks New Distribution Agreement For Croatia And Slovenia
7. Misonix And Soelim Create New Distribution Alliance For South Korea
8. Misonix Participates In Cleveland Spine Review
9. Misonix Adds Industry Veteran To Management Team
10. Misonix Exhibits at Major Worldwide Spine Conference
11. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy